Firm to conduct U.S. trial of dialysis device before year's end

11/22/2013 | American City Business Journals

Ambler, Pa.-based Bioconnect Systems is set to launch a U.S. clinical trial evaluating its OptiFlow system before the close of 2013. The technology is designed to enhance vascular access for patients undergoing dialysis by creating precisely controlled surgical connections that link a patient's vein to an artery.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY